8-96258669-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015942.5(MTERF3):c.22A>G(p.Ile8Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015942.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTERF3 | NM_015942.5 | c.22A>G | p.Ile8Val | missense_variant | 2/8 | ENST00000287025.4 | NP_057026.3 | |
MTERF3 | NM_001286643.1 | c.22A>G | p.Ile8Val | missense_variant | 2/9 | NP_001273572.1 | ||
MTERF3 | NM_001362964.1 | c.-514A>G | 5_prime_UTR_variant | 2/8 | NP_001349893.1 | |||
MTERF3 | XM_011517054.3 | c.-448A>G | 5_prime_UTR_variant | 2/8 | XP_011515356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTERF3 | ENST00000287025.4 | c.22A>G | p.Ile8Val | missense_variant | 2/8 | 1 | NM_015942.5 | ENSP00000287025 | P1 | |
MTERF3 | ENST00000523821.5 | c.22A>G | p.Ile8Val | missense_variant | 2/9 | 1 | ENSP00000429400 | |||
MTERF3 | ENST00000517720.1 | c.22A>G | p.Ile8Val | missense_variant | 3/3 | 3 | ENSP00000429526 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2023 | The c.22A>G (p.I8V) alteration is located in exon 2 (coding exon 1) of the MTERF3 gene. This alteration results from a A to G substitution at nucleotide position 22, causing the isoleucine (I) at amino acid position 8 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.